A study comparing 18f-Florbetaben quantification results using MR based and MR less CapAIBL and validation against histopathology.
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease; Amyloidosis
- Focus Diagnostic use
- 23 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017